Roberts Pharmaceutical Report issue

For profit Phase 2
Founded: Eatontown NJ United States (1983)
Status: Acquired by Shire (1999) → now Takeda (2018)

Organization Overview

First Clinical Trial
2001
NCT00004268
First Marketed Drug
2019
helium
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ROBERTS OXYGEN CO INC

Active Ingredients

Marketed Drugs (1)

helium (2019)

Drugs in Phase 2 Trials (1)

midodrine (proamatine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypotension (Phase 2)

Hypotension, Orthostatic (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1